MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-02.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $8.4B— | $8.7B+3.6% | $8.0B-8.2% | $7.8B-1.7% | $7.6B-3.4% |
| EPS (dil.) | $1.62— | $3.63+124.1% | $4.02+10.7% | $3.76-6.5% | $3.86+2.7% |
| Free Cash Flow | $802M— | $616M-23.2% | $1.2B+89.9% | $907M-22.5% | $866M-4.5% |
| Gross Margin | 34.2% | 31.3%-2.9pp | 35.2%+4.0pp | 36.3%+1.0pp | 35.5%-0.7pp |
| Operating Margin | 17.3% | 15.2%-2.1pp | 16.8%+1.5pp | 17.5%+0.8pp | 16.8%-0.7pp |
| Net Margin | 4.8% | 9.7%+4.9pp | 11.4%+1.7pp | 10.5%-0.9pp | 10.7%+0.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $81 (last qtr, 7 analysts) → $82 (last mo, 5) (+1.8%).
Buy-rated share 33% → 30% over ~3 months (-3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $1.02 | $1.19 | +16.7% |
| Jul 2026 | $1.32 | $1.64 | +24.2% |
| Apr 2026 | $0.88 | $1.04 | +18.6% |
| Feb 2026 | $0.78 | $0.82 | +5.1% |
| Oct 2025 | $1.02 | $0.97 | -4.9% |
| Jul 2025 | $1.09 | $1.30 | +19.3% |
| Apr 2025 | $0.92 | $0.87 | -4.9% |
| Feb 2025 | $0.88 | $0.89 | +1.7% |
No recent open-market insider transactions.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 1.9%/yr (revenue basis).
Base free cash flow $981M (avg FY2023–FY2025; latest year $866M) · equity value $15.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 54 for Masco Corporation suggests a neutral outlook, with the stock's short-term score exceeding its long-term score by 9 points. Masco scores high on momentum, driven by a 23.6% return over the past year and a bullish 50-day versus 200-day moving average trend. However, the stock's value and profitability scores are weighed down by a relatively high EV/EBITDA of 11.9 and a negative ROE, while its growth score is hindered by negative revenue and free cash flow growth.